Actively Recruiting
Taltz in Combination With Enstilar for Psoriasis
Led by Psoriasis Treatment Center of Central New Jersey · Updated on 2020-05-04
25
Participants Needed
1
Research Sites
48 weeks
Total Duration
On this page
Sponsors
P
Psoriasis Treatment Center of Central New Jersey
Lead Sponsor
E
Eli Lilly and Company
Collaborating Sponsor
AI-Summary
What this Trial Is About
Enstilar in combination with Taltz for plaque psoriasis.
CONDITIONS
Official Title
Taltz in Combination With Enstilar for Psoriasis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female adult 18 years of age or older
- Diagnosis of chronic plaque-type psoriasis
- Body Surface Area between 3% and 8%
- Treated with Taltz for a minimum of 24 weeks
- Females of childbearing potential must have a negative pregnancy test at Screening and Baseline
- Females of childbearing potential who can conceive must use approved contraception methods including hormonal contraception, IUD, tubal ligation, partner's vasectomy, or condom with spermicide
- Subject must be in general good health except for psoriasis as judged by the Investigator
- Able and willing to give written informed consent prior to any study procedures
You will not qualify if you...
- Body Surface Area less than 3% or greater than 8%
- Not receiving Taltz or receiving Taltz for less than 24 weeks
- Any condition posing unacceptable risk for study participation
- Pregnant or breastfeeding or planning pregnancy during the study
- Use of any investigational drug within 4 weeks prior to randomization or within 5 half-lives if known
- Use of oral systemic psoriasis medications within 4 weeks
- Use of other topical therapies within 2 weeks of Baseline Visit
- Received UVB phototherapy within 2 weeks of Baseline
- Received PUVA phototherapy within 4 weeks of Baseline
- Known hypersensitivity to excipients of Enstilar as stated in the label
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Psoriasis Treatment Center of Central New Jersey
East Windsor, New Jersey, United States, 08520
Actively Recruiting
Research Team
J
Jerry Bagel, MD
CONTACT
E
Elise Nelson
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here